► Customized research for ABBV vs. ABLYF!
► All in one page research, scroll down. Compare two other stocks.
► Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.
Done! Side by Side Research Below for ABBV vs. ABLYF.
↗ Join Our Free Email Newsletter.
► AbbVie Inc. vs. Ablynx NV
Industry Match! Industry of Both ABBV and ABLYF:
Health Care/Life Sciences
ABBV
Data Last Updated: More than a wk ago
↻ Update Column 1 to Most Recent
► Key Statistics
Cap: 127.947B
P/E: 39.74
P/S: 3.91
Q P/B: N/A
Y Rev: 32.75B
Q Rev: 8.48B
Beta: 0.95

ABBV Share Stats
► Outstanding Shares
1.48B
► Float Shares
1.48B
► Percent of Float Short
4.44%
ABBV Insider Stats
► Percent Outstanding Insider Ownership
N/A
► Percent Outstanding Institution Ownership
N/A
ABBV Social Stats
► Followers
1
► B/S Rating Today
0
► B/S Rating All-Time
+1
Share ABBV Insights
ABBV Profile
► CEO
Mr. Richard A. Gonzalez
► Exchange
NYSE
► Employees
30,000
► About
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including...

ABBV Financials
Annual Financials
Income Statement
► Revenue
32.75B
► Net Income
5.66B
Cash Flow Statement
► Change in Cash / Investments
(2.01B)
Balance Sheet
► Cash / Investments
8.06B
► Short Term Debt
3.7B
► Long Term Debt
35B
► Total Current Assets
16.95B
► Total Current Liabilities
17.24B
► Total Assets
59.35B
► Total Liabilities
67.8B
► Stockholder Equity
(8.45B)
Quarterly Financials
Income Statement
► Q Revenue
8.48B
► Q Net Income
1.88B
Cash Flow Statement
► Q Change in Cash / Investments
5.48B
Balance Sheet
► Q Cash / Investments
10.65B
► Q Short Term Debt
107M
► Q Long Term Debt
33.11B
► Q Total Current Assets
20.17B
► Q Total Current Liabilities
17.49B
► Q Total Assets
59.44B
► Q Total Liabilities
67.67B
► Q Stockholder Equity
(8.23B)

ABBV Charts
► 10-Year Chart

► 5-Year Chart

► 1-Year Chart

► 6-Month Chart

► 3-Month Chart

► 1-Month Chart

► 1-Day Chart

ABLYF
Data Last Updated: N/A
↻ Update Column 2 to Most Recent
► Key Statistics
Cap: N/A
P/E: N/A
P/S: N/A
Q P/B: N/A
Y Rev: 1.78B
Q Rev: 18.39B
Beta: N/A

ABLYF Share Stats
► Outstanding Shares
78M
► Float Shares
74.51M
► Percent of Float Short
N/A
ABLYF Insider Stats
► Percent Outstanding Insider Ownership
0.00%
► Percent Outstanding Institution Ownership
12.19%
ABLYF Social Stats
► Followers
0
► B/S Rating Today
0
► B/S Rating All-Time
N/A
Share ABLYF Insights
ABLYF Profile
► CEO
Mr. Serge Weinberg
► Exchange
OTC
► Employees
N/A
► About
Sanofi engages in the research, production and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Human Vaccines. The Pharmaceuticals segment comprises the commercial operations of...

ABLYF Financials
Annual Financials
Income Statement
► Revenue
1.78B
► Net Income
4.83%
Cash Flow Statement
► Change in Cash / Investments
42M
Balance Sheet
► Cash / Investments
6.93B
► Short Term Debt
2.63B
► Long Term Debt
22.01B
► Total Current Assets
24.58B
► Total Current Liabilities
17.38B
► Total Assets
111.41B
► Total Liabilities
52.37B
► Stockholder Equity
58.88B
Quarterly Financials
Income Statement
► Q Revenue
18.39B
► Q Net Income
2.59B
Cash Flow Statement
► Q Change in Cash / Investments
(2.82B)
Balance Sheet
► Q Cash / Investments
6.93B
► Q Short Term Debt
2.63B
► Q Long Term Debt
22.01B
► Q Total Current Assets
24.58B
► Q Total Current Liabilities
17.38B
► Q Total Assets
111.41B
► Q Total Liabilities
52.37B
► Q Stockholder Equity
58.88B

ABLYF Charts
► 10-Year Chart

► 5-Year Chart

► 1-Year Chart

► 6-Month Chart

► 3-Month Chart

► 1-Month Chart

► 1-Day Chart

